Yarlagadda S. Babu
2011
In 2011, Yarlagadda S. Babu earned a total compensation of $621.6K as Senior Vice President of Drug Discovery at BioCryst Pharmaceuticals, which was about the same as previous year.
Compensation breakdown
Non-Equity Incentive Plan | $110,028 |
---|---|
Option Awards | $138,500 |
Salary | $323,452 |
Stock Awards | $37,350 |
Other | $12,250 |
Total | $621,580 |
Babu received $323.5K in salary, accounting for 52% of the total pay in 2011.
Babu also received $110K in non-equity incentive plan, $138.5K in option awards, $37.4K in stock awards and $12.3K in other compensation.
Rankings
In 2011, Yarlagadda S. Babu's compensation ranked 7,364th out of 10,747 executives tracked by ExecPay. In other words, Babu earned more than 31.5% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 7,364 | 32nd |
Manufacturing | 2,692 | 32nd |
Chemicals And Allied Products | 661 | 36th |
Drugs | 460 | 41st |
Biological Products, Except Diagnostic Substances | 78 | 50th |
Babu's colleagues
We found five more compensation records of executives who worked with Yarlagadda S. Babu at BioCryst Pharmaceuticals in 2011.
2011
Jon Stonehouse
BioCryst Pharmaceuticals
Chief Executive Officer
2011
Thomas Staab
BioCryst Pharmaceuticals
Chief Financial Officer
2011
William Sheridan
BioCryst Pharmaceuticals
Chief Medical Officer
2011
David McCullough
BioCryst Pharmaceuticals
Vice President, Strategic Planning, Commercialization and Corporate Development
2011
Stuart Grant
BioCryst Pharmaceuticals